Prof. Dr. Marco Durante is Director of the Biophysics Department at the GSI Helmholtz Center for Heavy Ion Research (Darmstadt, Germany) and Full Professor of Physics at the Technical University of Darmstadt. He got his Ph.D. in Physics in 1992 at the University Federico II in Italy, and has dedicated his research efforts to the biophysics of high-energy charged particles, with applications in cancer therapy and space radiation protection. He is generally recognized as a world leader in the field of particle radiobiology and medical physics and is co-author of over 400 papers in peer-reviewed scientific journals (h-index=55) and one patent on proton therapy. He is currently the chair of the ESA Topical Team on Space Radiation and vice-chair of the Particle Therapy Co-Operative Group (PTCOG). Prof. Durante has been awarded several prizes for his contributions to charged particle biophysics, including the 2004 Galileo Galilei Award in Medical Physics, the 60th Timofeeff-Ressovsky medal by the Russian Academy of Sciences, the 8th Warren K. Sinclair Award of the US National Academy of Sciences, the 2013 IBA-Europhysics Award for Applied Nuclear Science and Nuclear Methods in Medicine (European Physics Society), the 2013 Bacq & Alexander award of the European Radiation Research Society (ERRS), and the 2020 Failla award of the Radiation research Society (RRS). He is a recipient of an ERC Advanced Grant in 2020 on particle therapy.
Prof. Dr. Marco Durante is Director of the Biophysics Department at the GSI Helmholtz Center for Heavy Ion Research (Darmstadt, Germany) and Full Professor of Physics at the Technical University of Darmstadt. He got his Ph.D. in Physics in 1992 at the University Federico II in Italy, and has dedicated his research efforts to the biophysics of high-energy charged particles, with applications in cancer therapy and space radiation protection. He is generally recognized as a world leader in the field of particle radiobiology and medical physics and is co-author of over 400 papers in peer-reviewed scientific journals (h-index=55) and one patent on proton therapy. He is currently the chair of the ESA Topical Team on Space Radiation and vice-chair of the Particle Therapy Co-Operative Group (PTCOG). Prof. Durante has been awarded several prizes for his contributions to charged particle biophysics, including the 2004 Galileo Galilei Award in Medical Physics, the 60th Timofeeff-Ressovsky medal by the Russian Academy of Sciences, the 8th Warren K. Sinclair Award of the US National Academy of Sciences, the 2013 IBA-Europhysics Award for Applied Nuclear Science and Nuclear Methods in Medicine (European Physics Society), the 2013 Bacq & Alexander award of the European Radiation Research Society (ERRS), and the 2020 Failla award of the Radiation research Society (RRS). He is a recipient of an ERC Advanced Grant in 2020 on particle therapy.